IGHMBP2
protein-codingimmunoglobulin mu DNA binding protein 2, the group of UPF1 like RNA helicases|Zinc fingers AN1-type
Gene summary
This gene encodes a helicase superfamily member that binds a specific DNA sequence from the immunoglobulin mu chain switch region. Mutations in this gene lead to spinal muscle atrophy with respiratory distress type 1. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~36.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0011436
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0020127
Submitter: ClinGen
IGHMBP2 was first reported in 2001 as a cause of autosomal recessive distal hereditary motor neuronopathy VI (DHMN6), also referred to as Spinal Muscular Atrophy with Respiratory Distress (SMARD1) (Grohmann et al., 2001; PMID: 11528396). In 2014, variants in IGHMBP2 were reported in patients with autosomal recessive Charcot Marie Tooth disease, axonal, type 2S (CMT2S) who displayed no signs of respiratory distress (Cottenie et al., 2014; PMID: 25439726). Per criteria outlined by the ClinGen Lumping and Splitting Working group, SMARD1 (OMIM: 604320) and CMT2S (OMIM: 616155) were lumped into the single disease entity, hereditary peripheral neuropathy (MONDO:0020127), to account for the disease spectrum associated with variants in this gene. No discrepancies were found between the inheritance pattern and the molecular mechanism, as both were identified as autosomal recessive and loss-of-function. This mechanism of pathogenicity is reinforced by functional evidence derived from Western blot analysis showing a significant reduction in protein expression (PMID: 25439726). IGHMBP2 encodes an ATP-dependent RNA/DNA helicase that binds DNA from the immunoglobulin mu chain switch region. It is highly conserved and believed to be involved in the regulation of DNA replication, pre-mRNA splicing, transcription, and translation. Included in this curation are two publications that report a total of eleven variants within nine probands, giving a max score of 12 points for genetic evidence (PMID: 11528396, PMID: 25439726). Pathogenic variants were comprised of homozygous or compound heterozygous nonsense, missense, frameshift, and splice donor variants. Additionally, the gene-disease association was further supported by experimental evidence including expression data in motor neurons and patients, mouse models with neuromuscular degeneration phenotypes, and rescue in mouse models via AAV-mediated gene replacement therapy, providing a functional score of 5 points. (PMID: 7749225, PMID: 26601156, PMID: 15269181, PMID: 25439726). In summary, IGHMBP2 is definitively associated with autosomal recessive peripheral neuropathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.
Inheritance Pattern: AR
Disease ID:MONDO:0011436
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014511
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0011436
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014511
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Inheritance Pattern: AR
Disease ID:MONDO:0014511
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0020127
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0011436
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0011436
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014511
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to IGHMBP2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002180.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 10 | 379 | 7 | 396 | ||
| missense | 8 | 57 | 514 | 45 | 6 | 630 |
| nonsense | 21 | 15 | 6 | 42 | ||
| start loss | 1 | 1 | ||||
| frameshift | 54 | 17 | 7 | 78 | ||
| splice donor/acceptor (+/-2bp) | 7 | 21 | 2 | 30 | ||
| Total | 90 | 111 | 539 | 424 | 13 | 1177 |
Highest pathogenic variant AF is 0.00034800646
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002171.2 | 15 | MANE Select | |
| Ensembl | ENSP00000255078.4 | 15 | MANE Select | |
| Ensembl | ENSP00000440465.2 | 6 | Standard | |
| Ensembl | ENSP00000456366.1 | 2 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- DNA replication
- DNA repair
- DNA recombination
- translation
- DNA duplex unwinding
Molecular Function
- tRNA binding
- DNA binding
- DNA helicase activity
- single-stranded DNA binding
- RNA binding
Cellular Component
- nucleus
- cytoplasm
- membrane
- axon
- growth cone
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000255078
- Coding exons
- 15
- Length
- 36761
- Individuals with no LoFs
- 125607
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 141
- Defined
- 125748
- p
- 0.000561
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.176 | 580 | 592 | 0.980 | 0.0000399 | 6378 |
| Missense (PolyPhen) | 192 | 207.34 | 0.92604 | 2161 | ||
| Synonymous | -1.40 | 287 | 258 | 1.11 | 0.0000188 | 2081 |
| Loss of Function | 1.81 | 31 | 43.9 | 0.706 | 0.00000283 | 464 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00019 | 0.00018 | rare |
| Latino/Admixed American | 0.00039 | 0.00038 | rare |
| Ashkenazi Jewish | 0.00030 | 0.00030 | rare |
| East Asian | 0.00082 | 0.00082 | rare |
| Finnish | 0.00047 | 0.00042 | rare |
| European (Non-Finnish) | 0.00075 | 0.00072 | rare |
| South Asian | 0.00062 | 0.00042 | rare |
| Other | 0.00049 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: 5' to 3' helicase that unwinds RNA and DNA duplices in an ATP-dependent reaction. Acts as a transcription regulator. Required for the transcriptional activation of the flounder liver- type antifreeze protein gene. Exhibits strong binding specificity to the enhancer element B of the flounder antifreeze protein gene intron. Binds to the insulin II gene RIPE3B enhancer region. May be involved in translation (By similarity). DNA-binding protein specific to 5'-phosphorylated single-stranded guanine-rich sequence related to the immunoglobulin mu chain switch region. Preferentially binds to the 5'-GGGCT-3' motif. Interacts with tRNA-Tyr. Stimulates the transcription of the human neurotropic virus JCV. {ECO:0000250, ECO:0000269|PubMed:19158098, ECO:0000269|PubMed:19299493}.;
- Disease
- DISEASE: Charcot-Marie-Tooth disease 2S (CMT2S) [MIM:616155]: An axonal form of Charcot-Marie-Tooth disease, a disorder of the peripheral nervous system, characterized by progressive weakness and atrophy, initially of the peroneal muscles and later of the distal muscles of the arms. Charcot-Marie-Tooth disease is classified in two main groups on the basis of electrophysiologic properties and histopathology: primary peripheral demyelinating neuropathies (designated CMT1 when they are dominantly inherited) and primary peripheral axonal neuropathies (CMT2). Neuropathies of the CMT2 group are characterized by signs of axonal degeneration in the absence of obvious myelin alterations, normal or slightly reduced nerve conduction velocities, and progressive distal muscle weakness and atrophy. {ECO:0000269|PubMed:25439726}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.199
Intolerance Scores
- LoFtool
- 0.0776
- RVIS EVS
- 0.86
- RVIS percentile EVS
- 88.57
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.818
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |